Diagnosis of Alzheimer Disease Using Pla...

Dr. Dara Albert talks with Dr. Scott Perry about improving the transition from pediatric to adult epilepsy care. Read the related article in Neurology® Clinical Practice. Disclosures can be found at Neurology.org. 

Dr. Greg Cooper talks with Dr. Elisabeth Kurpershoek about how clinicians communicate uncertainty during Parkinson disease diagnosis and how this impacts patient trust and understanding. Read the related article in Neurology® Clinical Practice. Disclosures can be found at Neurolo ... Show More

The July 2026 Recall features four previously posted episodes related to updates in epilepsy. The episode opens with Dr. Rosemary Dray-Spira discussing trends in prenatal exposure to antiseizure medications over the past decade. The episode continues with Dr. Page Pennell discuss ... Show More

<p>The diagnostic paradigm for Alzheimer&apos;s disease (AD) has rapidly shifted in the last five years as fluid-based biomarker testing has emerged as a reliable, accurate, and accessible means to detect amyloid pathology when evaluating a patient for cognitive decline. This pod ... Show More

Dr. Rae Bacharach discusses the Neurology Today article, "Individuals Can Now Request a Blood Test for Alzheimer disease - Why Some Dementia Experts Are Wary". Show references: https://journals.lww.com/neurotodayonline/fulltext/2023/10190/individuals_can_now_request_a_blood_test_ ... Show More

What are Biomarkers? And why are they useful in Alzheimer's Disease Research. 

Dr. Manisha Bahl interviews Dr. Jeffrey Prescott. Diffuse Tensor MRI Structural Connectivity and PET Amyloid Burden in Preclinical Autosomal Dominant Alzheimer Disease: The DIAN Cohort. Prescott et al. Radiology 2022; 302:143–150.  

There are 6 million Americans living with Alzheimer's Disease. This program explains the latest understanding of the anatomy and functions of the brain and how it relates to neurological diseases. Dr. Gil Rabinovici is at the forefront of novel diagnostic testing to detect Alzhei ... Show More

Dr. Jason Crowell talks with Dr. Christopher Gibbons to discuss his paper "Cutaneous Phosphorylated Alpha-Synuclein Deposition in Dementia with Lewy Bodies and Mild Cognitive Impairment."   Show reference:  https://index.mirasmart.com/AAN2024/SearchResults.php?Program_Number=PL4. ... Show More

Following National Alzheimer’s Disease Awareness Month, the CDC shares what physicians and patients need to know about the disease. Lisa McGuire, PhD, lead epidemiologist at the CDC, discusses the importance of catching Alzheimer’s early, its risk factors and barriers to make Alz ... Show More

<p>In this interview, dementia expert Gil D. Rabinovici, MD, discusses monoclonal antibodies that target beta-amyloid–-including a recent phase 3 trial of donanemab published in JAMA-–and reviews considerations for their use in patients with Alzheimer disease.<br /> <br /> <stron ... Show More

This episode explores the current state of research on the multiple likely mechanisms of Alzheimer’s disease as well as promising treatments and diagnostics. A full transcript of this episode is available at nejm.org/doi/full/10.1056/NEJMp2309944. 

<p class="MsoNormal">This episode is a conversation with Drs. Clifford Jack and Kevin Duff about recent updates to the diagnosis and staging of Alzheimer's disease (AD). We discuss biological versus clinical/pathological approaches to diagnosing AD, analogies between AD and other ... Show More